
自引率: 3.9%
被引量: 2489
通过率: 暂无数据
审稿周期: 2
版面费用: 暂无数据
国人发稿量: 15
投稿须知/期刊简介:
Published by International Medical Press. ISSN: 1359-6535.<br /><br />The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets' such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research
期刊描述简介:
The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets' such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research
-
Antiviral potential of phenolic compounds against HSV-1: In-vitro study.
被引量:- 发表:2024
-
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort.
被引量:- 发表:2024
-
Andrographolide suppresses SARS-CoV-2 infection by downregulating ACE2 expression: A mechanistic study.
被引量:- 发表:2024
-
Assessment of swallowability and acceptability of scored darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose combination (FDC) tablets in HIV-1-infected children aged ≥6 to <12 years, using matching placebo tablets: A randomize
被引量:- 发表:2024
-
Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA.
被引量:3 发表:2023